A study to demonstrate the safety and efficacy of lopinavir/ritonavir (LPV/r) monotherapy as second-line of treatment in a resource-limited setting.
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 18 Dec 2015 New trial record